ENOV vs SMTI: stock comparison and AI forecast
Enovis Corp (ENOV) and Sanara Medtech Inc. (SMTI) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ENOV Enovis Corp
- Market Cap
- $1.57B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SMTI Sanara Medtech Inc.
- Price
- $31.55 +75.1% · 6M
- Market Cap
- $290M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- ENOV is 5.4 times larger than SMTI by market capitalization ($1.57B against $290M).
- ENOV turns -22.9% of its revenue into net income, against -29.2% for SMTI.
- SMTI carries 7.71 times debt per unit of equity, against 1.50 times for ENOV.
- Both companies share the SEC industry classification Orthopedic, Prosthetic & Surgical Appliances & Supplies.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ENOV | SMTI |
|---|---|---|
| Market Cap | $1.57B | $290M |
| P/B Ratio | 1.05x | 36.49x |
| EPS | $-10.06 | $-4.13 |
| Book Value/Share | $25.89 | $0.86 |
| Revenue/Share | $39.99 | $11.95 |
| FCF/Share | $1.21 | $0.49 |
Profitability & Margins
| Metric | ENOV | SMTI |
|---|---|---|
| ROE | -35.3% | -403.0% |
| ROA | -14.1% | -46.3% |
| ROIC | -15.1% | 24.4% |
| Gross Margin | 61.3% | 93.0% |
| Operating Margin | -20.6% | 12.6% |
| Net Margin | -22.9% | -29.2% |
| EBT Margin | -21.8% | 5.6% |
| Tax Rate | -5.0% | 0.1% |
Financial Health
| Metric | ENOV | SMTI |
|---|---|---|
| Current Ratio | 2.15x | 2.58x |
| Quick Ratio | 1.08x | 2.30x |
| D/E Ratio | 1.50x | 7.71x |
| Financial Leverage | 2.50x | 8.70x |
| Interest Coverage | 0.4x | 1.0x |
| Working Capital | $668M | $20M |
Cash Flow
| Metric | ENOV | SMTI |
|---|---|---|
| Operating Cash Flow | $259M | $6M |
| Free Cash Flow | $70M | $4M |
| Capital Spending | -$189M | -$1M |
| OCF Growth YoY | 19.3% | 56.1% |
| FCF Growth YoY | 205.6% | 5368.1% |
| FCF/Sales | 3.0% | 4.1% |
| CapEx/Sales | 8.2% | 1.1% |
Operational Efficiency
| Metric | ENOV | SMTI |
|---|---|---|
| Asset Turnover | 0.62x | 1.59x |
| Receivables Turnover | 5.4x | 8.7x |
| Inventory Turnover | 1.4x | 2.2x |
| Fixed Assets Turnover | 4.4x | 257.2x |
| Days Sales Outstanding | 68 days | 42 days |
| Days Inventory | 254 days | 165 days |
| Payables Period | 82 days | 67 days |
| Cash Conversion Cycle | 239 days | 140 days |
Income Statement
| Metric | ENOV | SMTI |
|---|---|---|
| Total Revenue | $2.31B | $110M |
| Operating Income | -$475M | $14M |
| Net Income | -$527M | -$32M |
| R&D Expense | $126M | $5M |
| SG&A Expense | $1.08B | $80M |
| Cost of Goods Sold | $892M | $8M |
Dividend & Shareholder Information
| Metric | ENOV | SMTI |
|---|---|---|
| Shares Outstanding | 58M | 9M |
ENOV vs SMTI: stock comparison and AI forecast
Which is bigger, ENOV or SMTI?
ENOV is 5.4 times larger than SMTI by market capitalization ($1.57B against $290M).
Which one does Intratio's AI model rank higher, ENOV or SMTI?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.